Cargando…
Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders
BACKGROUND: Diabetes mellitus (DM) has reached epidemic proportions and is an important risk factor for heart failure (HF). Left ventricular diastolic dysfunction (LVDD) is recognized as the earliest manifestation of DM-induced LV dysfunction, but its pathophysiology remains incompletely understood....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778641/ https://www.ncbi.nlm.nih.gov/pubmed/19909503 http://dx.doi.org/10.1186/1475-2840-8-58 |
_version_ | 1782174279645790208 |
---|---|
author | Dinh, Wilfried Füth, Reiner Nickl, Werner Krahn, Thomas Ellinghaus, Peter Scheffold, Thomas Bansemir, Lars Bufe, Alexander Barroso, Michael Coll Lankisch, Mark |
author_facet | Dinh, Wilfried Füth, Reiner Nickl, Werner Krahn, Thomas Ellinghaus, Peter Scheffold, Thomas Bansemir, Lars Bufe, Alexander Barroso, Michael Coll Lankisch, Mark |
author_sort | Dinh, Wilfried |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus (DM) has reached epidemic proportions and is an important risk factor for heart failure (HF). Left ventricular diastolic dysfunction (LVDD) is recognized as the earliest manifestation of DM-induced LV dysfunction, but its pathophysiology remains incompletely understood. We sought to evaluate the relationship between proinflammatory cytokine levels (TNF-alpha, IL-6) and tissue Doppler derived indices of LVDD in patients with stable coronary artery disease. METHODS: We enrolled 41 consecutive patients (mean age 65+/-10 years) submitted for coronary angiography. Echocardiographic assessment was performed in all patients. Pulsed tissue Doppler imaging was performed at the mitral annulus and was characterized by the diastolic early relaxation velocity Em. Conventional transmitral flow was measured with pw-doppler. Early (E) transmitral flow velocity was measured. LVDD was defined as E/Em ratio ≥ 15, E/Em 8-14 was classified as borderline. Plasma levels of TNF-alpha and IL-6 were determined in all patients. A standardized oral glucose tolerance test was performed in subjects without diabetes. RESULTS: Patients with E/Em ratio ≥ 15, classified as LVDD and those with E/Em ratio 8-14 (classified as borderline) had significantly higher IL-6 (P = 0,001), TNF-alpha (P < 0,001) and NT-pro- BNP (P = 0,001) plasma levels compared to those with normal diastolic function. TNF-alpha and IL-6 levels remains significantly elevated after adjustment for sex, age, left ventricular ejection function, body mass index, coronary heart disease, smoking, hypertension and diabetes mellitus with linear regression analysis. Furthermore, in subjects LVDD or borderline LV diastolic function, 75% had diabetes or IGT, respectively. When subjects without diabetes were excluded, both IL-6 (P = 0,006) and TNF-alpha (P = 0,002) remained significantly elevated in subjects with E/Em ratio ≥ 15. CONCLUSION: This study reveals that increased plasma levels of IL-6 and TNF-alpha were associated with LVDD. These findings suggest a link between low-grade inflammation and the presence of LVDD. An active proinflammatory process may be of importance in the pathogenesis of diastolic dysfunction. |
format | Text |
id | pubmed-2778641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27786412009-11-18 Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders Dinh, Wilfried Füth, Reiner Nickl, Werner Krahn, Thomas Ellinghaus, Peter Scheffold, Thomas Bansemir, Lars Bufe, Alexander Barroso, Michael Coll Lankisch, Mark Cardiovasc Diabetol Original investigation BACKGROUND: Diabetes mellitus (DM) has reached epidemic proportions and is an important risk factor for heart failure (HF). Left ventricular diastolic dysfunction (LVDD) is recognized as the earliest manifestation of DM-induced LV dysfunction, but its pathophysiology remains incompletely understood. We sought to evaluate the relationship between proinflammatory cytokine levels (TNF-alpha, IL-6) and tissue Doppler derived indices of LVDD in patients with stable coronary artery disease. METHODS: We enrolled 41 consecutive patients (mean age 65+/-10 years) submitted for coronary angiography. Echocardiographic assessment was performed in all patients. Pulsed tissue Doppler imaging was performed at the mitral annulus and was characterized by the diastolic early relaxation velocity Em. Conventional transmitral flow was measured with pw-doppler. Early (E) transmitral flow velocity was measured. LVDD was defined as E/Em ratio ≥ 15, E/Em 8-14 was classified as borderline. Plasma levels of TNF-alpha and IL-6 were determined in all patients. A standardized oral glucose tolerance test was performed in subjects without diabetes. RESULTS: Patients with E/Em ratio ≥ 15, classified as LVDD and those with E/Em ratio 8-14 (classified as borderline) had significantly higher IL-6 (P = 0,001), TNF-alpha (P < 0,001) and NT-pro- BNP (P = 0,001) plasma levels compared to those with normal diastolic function. TNF-alpha and IL-6 levels remains significantly elevated after adjustment for sex, age, left ventricular ejection function, body mass index, coronary heart disease, smoking, hypertension and diabetes mellitus with linear regression analysis. Furthermore, in subjects LVDD or borderline LV diastolic function, 75% had diabetes or IGT, respectively. When subjects without diabetes were excluded, both IL-6 (P = 0,006) and TNF-alpha (P = 0,002) remained significantly elevated in subjects with E/Em ratio ≥ 15. CONCLUSION: This study reveals that increased plasma levels of IL-6 and TNF-alpha were associated with LVDD. These findings suggest a link between low-grade inflammation and the presence of LVDD. An active proinflammatory process may be of importance in the pathogenesis of diastolic dysfunction. BioMed Central 2009-11-12 /pmc/articles/PMC2778641/ /pubmed/19909503 http://dx.doi.org/10.1186/1475-2840-8-58 Text en Copyright ©2009 Dinh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original investigation Dinh, Wilfried Füth, Reiner Nickl, Werner Krahn, Thomas Ellinghaus, Peter Scheffold, Thomas Bansemir, Lars Bufe, Alexander Barroso, Michael Coll Lankisch, Mark Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
title | Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
title_full | Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
title_fullStr | Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
title_full_unstemmed | Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
title_short | Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
title_sort | elevated plasma levels of tnf-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders |
topic | Original investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778641/ https://www.ncbi.nlm.nih.gov/pubmed/19909503 http://dx.doi.org/10.1186/1475-2840-8-58 |
work_keys_str_mv | AT dinhwilfried elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT futhreiner elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT nicklwerner elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT krahnthomas elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT ellinghauspeter elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT scheffoldthomas elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT bansemirlars elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT bufealexander elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT barrosomichaelcoll elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders AT lankischmark elevatedplasmalevelsoftnfalphaandinterleukin6inpatientswithdiastolicdysfunctionandglucosemetabolismdisorders |